AlvaroJoseAlencarMD

PubMed

• Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
  Ahn, I., Brander, D., Ren, Y., Zhou, Y., Tyekucheva, S., Walker, H., Black, R., Montegaard, J., Alencar, A., Shune, L., Omaira, M., Jacobson, C., Armand, P., Ng, S., C...> ;Blood Advances. 2024 Feb 27
• 3 citations
  Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
  Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yun...> ;Science. 2024 Feb 2
• 19 citations
  Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
  Anthony R Mato, Jennifer A Woyach, Jennifer R Brown, Paolo Ghia, Krish Patel, Toby A Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S Tam, Nirav N Sh...> ;The New England Journal of Medicine. 2023 Jul 6
• 5 citations
  Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
  Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A Eyre, Chan Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian Flinn, Benoit Tessouli...> ;Journal of Clinical Oncology. 2023 Aug 20
• A balancing act between toxicity and deep response.
  Carlos Chiattone, Alvaro J Alencar> ;Blood. 2022 Dec 1
• MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN...
  Jonathon B Cohen, Nirav N Shah, Alvaro J Alencar, James N Gerson, Manish R Patel, Bita Fakhri, Wojciech Jurczak, Xuan Ni Tan, Katharine L Lewis, Timothy Fenske, Cather...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• 2 citations
  Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International P...
  Sara Steffanoni, Teresa Calimeri, Alice Laurenge, Christopher P Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Lu...> ;British Journal of Haematology. 2022 Nov 1
• The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products.
  Nina Nguyen, Ellen Madarang, Alvaro Alencar, Justin Watts, Terrence Bradley> ;Leukemia Research Reports. 2022 Jan 1
• 2 citations
  Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical ...
  Diego V. Clé, Alexandre V. Hirayama, Alvaro J. Alencar, Luciano J. Costa, João V P Feliciano, Ederson R Mattos, Ana Cordeiro, Marco Aurelio Salvino, George M. N. Barro...> ;Hematology, Transfusion and Cell Therapy. 2021 Nov 1
• Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Ho...
  Alvaro J. Alencar, Alexandre V. Hirayama, Diego V. Clé, Marco Aurelio Salvino, Guilherme Fleury Perini, Celso Arrais, Otavio C. G. Baiocchi, LC Palma, Iago Colturato, ...> ;Hematology, Transfusion and Cell Therapy. 2021 Nov 1
• 1 citations
  R‐MACLO‐IVAM regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma ‐ long term follow up results
  Juan Pablo Alderuccio, Eduardo Edelman Saul, Sunil Iyer, Isildinha M. Reis, Alvaro J. Alencar, Joseph D. Rosenblatt, Izidore S. Lossos> ;American Journal of Hematology. 2021 Jun 1
• 203 citations
  Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
  Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Yoon Cheah, John M. Pagel, Jennifer A. Woyach, Bita Fakhri, Toby A. Eyre, Nicole Lamanna, Manish R. Patel, Alvar...> ;Lancet. 2021 Mar 6
• 9 citations
  Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma.
  Alvaro J. Alencar, Craig H. Moskowitz> ;Journal of Clinical Oncology. 2021 Jan 12
• 3 citations
  A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System
  Stephen D. Nimer, Jennifer R. Chapman, Lisa Reidy, Alvaro J. Alencar, Yan Yun Wu, Sion L. Williams, Lazara Pagan, Lauren N. Gjolaj, Jessica MacIntyre, Melissa Triana, ...> ;Academic Pathology. 2020 Sep 30
• Adult Langerhans cell histiocytosis presenting with multisystem involvement and sarcomatoid features: a case report
  Jennifer R. Chapman, Marcelo Larsen, Alvaro J. Alencar, Luis E. Aguirre, Ingrid Schwartz> ;Journal of Medical Case Reports. 2020 Sep 27
• 6 citations
  Unusual Variants of Follicular Lymphoma: Case-based Review.
  Jennifer R. Chapman, Jessica P. Alvarez, Kyle White, Sandra Sanchez, Mahsa Khanlari, Khaled Algashaamy, Daniel P. Cassidy, Jing Hong Peng, Yao Shan Fan, Alvaro J. Alen...> ;The American Journal of Surgical Pathology. 2020 Mar 1
• 3 citations
  Disseminated cutaneous immunoglobulin M macroglobulinosis associated with cryoglobulinemia and minimal residual disease of Waldenström macroglobulinemia.
  Rachel Fayne, Miranda Rosenberg, Kyle White, Alvaro J. Alencar, Robert S. Kirsner, Francisco Vega, Jeong Hee Cho-Vega> ;JAAD Case Reports. 2019 Oct 1
• 52 citations
  Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, ph...
  Matthew S. Davids, Danielle M. Brander, Haesook T. Kim, Svitlana Tyekucheva, Alexandra Savell, Jeffrey M Hellman, Josie Bazemore, Karen Francoeur, Alvaro J. Alencar, L...> ;The Lancet. Haematology. 2019 Aug 1
• 7 citations
  Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma.
  Alvaro J. Alencar, Craig H. Moskowitz> ;Nature Reviews. Clinical Oncology. 2019 Jul 15
• Invasive fusariosis masquerading as extramedullary disease in rapidly progressive acute lymphoblastic leukemia
  John A. Ligon, Mukil Natarajan, Haneen Shalabi, Bonnie Yates, Rachel Bishop, David Bianchi, Alvaro J. Alencar, Michail S. Lionakis, Nirali N. Shah> ;Pediatric Blood & Cancer. 2019 Jul 1
• 22 citations
  Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.
  Juan Pablo Alderuccio, Wei Zhao, Amrita Desai, Jeremy Ramdial, Nicolas Gallastegui, Erik Kimble, Macarena I. de la Fuente, Muhammad Husnain, Joseph D. Rosenblatt, Alva...> ;American Journal of Hematology. 2019 May 1
• 3 citations
  Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall.
  Khaled Algashaamy, Yaohong Tan, Nicolas Mackrides, Alvaro Alencar, Jing-Hong Peng, Joseph D Rosenblatt, Juan Pablo Alderuccio, Izidore S. Lossos, Francisco Vega, Jenni...> ;Case Reports in Hematology. 2018 Sep 27
• 38 citations
  MiR-181 family-specific behavior in different cancers: a meta-analysis view.
  Cecilia Pop-Bica, Sebastian Pintea, Roxana Cojocneanu-Petric, Giannino Del Sal, Silvano Piazza, Zhao-Hui Wu, Alvaro J. Alencar, Izidore S. Lossos, Ioana Berindan-Neago...> ;Cancer Metastasis Reviews. 2018 Mar 1
• 108 citations
  MicroRNAs are Independent Predictors of Outcome in Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP
  Alvaro J. Alencar, Raquel Malumbres, Goldi A. Kozloski, Ranjana H. Advani, Neha Talreja, Shideh Chinichian, Javier Briones, Yasodha Natkunam, Laurie H. Sehn, Randy D. ...> ;Clinical Cancer Research. 2011 Jun 15
• 158 citations
  Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
  Ash A. Alizadeh, Andrew J. Gentles, Alvaro J. Alencar, Chih Long Liu, Holbrook E Kohrt, Roch Houot, Matthew J. Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H. Ad...> ;Blood. 2010 Nov 19
• Join now to see all

Abstracts/Posters

• R-MACLO-IVAM Is an Effective Regimen to Induce Long Term Remission in Untreated Mantle Cell Lymphoma
  Alvaro J. Alencar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019